Psilocybin for Hospitalized Patients with Treatment-resistant Depression

NCT06378229 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: Psilocybin

Sponsor

University Hospital, Ghent

Collaborators

[object Object]